Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1991 Sep;29(9):1789–1794. doi: 10.1128/jcm.29.9.1789-1794.1991

Antibody levels and in vitro lymphoproliferative responses to Streptococcus pyogenes erythrogenic toxin A and mitogen of patients with rheumatic fever.

G M Bahr 1, A M Yousof 1, K Behbehani 1, H A Majeed 1, S Sakkalah 1, K Souan 1, I Jarrad 1, C Geoffroy 1, J E Alouf 1
PMCID: PMC270212  PMID: 1774298

Abstract

We investigated the in vitro lymphoproliferative responses to a streptococcal mitogen and erythrogenic toxin A of children with acute rheumatic fever (ARF) and patients with chronic rheumatic heart disease (CRHD). Antibody levels to the streptococcal products were also analyzed in the sera of those with ARF or chronic rheumatic heart disease as well as in the sera of children with streptococcal pharyngitis or poststreptococcal glomerulonephritis. Our results demonstrated that the individuals had depressed lymphoproliferative responses during the active stage of rheumatic fever. The depressed responses were not found either to be induced by time-sensitive mitogen-specific suppressor cells or to be related to a dose-response phenomenon. On the other hand, antibody levels to the extracellular mitogens were significantly elevated in the sera of children with ARF compared with the levels in the rest of the groups. The hyperresponsiveness noted among children with ARF was found to be at a quantitative level and was not due to recognition of more epitopes, as determined by Western blotting (immunoblotting). The profile of immune responsiveness in children with ARF to the streptococcal extracellular mitogens is discussed in relation to the pathogenesis of disease.

Full text

PDF
1789

Images in this article

1792Image
on p.1792

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe Y., Alouf J. E., Kurihara T., Kawashima H. Species-dependent response to streptococcal lymphocyte mitogens in rabbits, guinea pigs, and mice. Infect Immun. 1980 Aug;29(2):814–818. doi: 10.1128/iai.29.2.814-818.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abou-Zeid C., Smith I., Grange J., Steele J., Rook G. Subdivision of daughter strains of bacille Calmette-Guérin (BCG) according to secreted protein patterns. J Gen Microbiol. 1986 Nov;132(11):3047–3053. doi: 10.1099/00221287-132-11-3047. [DOI] [PubMed] [Google Scholar]
  3. Alouf J. E., Geoffroy C., Klatzmann D., Gluckman J. C., Gruest J., Montagnier L. High production of the acquired immunodeficiency syndrome virus (lymphadenopathy-associated virus) by human T lymphocytes stimulated by streptococcal mitogenic toxins. J Clin Microbiol. 1986 Oct;24(4):639–641. doi: 10.1128/jcm.24.4.639-641.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ayoub E. M. The search for host determinants of susceptibility to rheumatic fever: the missing link. T. Duckett Jones Memorial Lecture. Circulation. 1984 Jan;69(1):197–201. doi: 10.1161/01.cir.69.1.197. [DOI] [PubMed] [Google Scholar]
  5. Bahr G. M., Rook G. A., Moreno E., Lydyard P. M., Modabber F. Z., Stanford J. L. Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE. Immunology. 1980 Dec;41(4):865–873. [PMC free article] [PubMed] [Google Scholar]
  6. Bahr G. M., Rook G. A., Stanford J. L. Inhibition of the proliferative response of peripheral blood lymphocytes to mycobacterial or fungal antigens by co-stimulation with antigens from various mycobacterial species. Immunology. 1981 Nov;44(3):593–598. [PMC free article] [PubMed] [Google Scholar]
  7. Bahr G. M., Rook G. A., Stanford J. L., Lydyard P. M., Bryceson A. D. The effect of delayed addition of antigen and 'E' rosetting on the proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal individuals or from patients with tuberculosis or leprosy. Immunology. 1981 Nov;44(3):585–591. [PMC free article] [PubMed] [Google Scholar]
  8. Bahr G. M., Yousof A. M., Majeed H., Chedid L., Behbehani K. Antibodies to a streptococcal cell wall adjuvant structure persist in patient with chronic rheumatic heart disease. J Mol Cell Cardiol. 1989 Jan;21(1):61–66. doi: 10.1016/0022-2828(89)91493-4. [DOI] [PubMed] [Google Scholar]
  9. Benatar A., Beatty D. W., Human D. G. Immunological abnormalities in children with acute rheumatic carditis and acute post-streptococcal glomerulonephritis. Int J Cardiol. 1988 Oct;21(1):51–58. doi: 10.1016/0167-5273(88)90008-3. [DOI] [PubMed] [Google Scholar]
  10. Cavaillon J. M., Alouf J. E. Mitogenicity of streptococcal extracellular products and antagonism with concanavalin A. Immunol Lett. 1982;5(6):317–322. doi: 10.1016/0165-2478(82)90120-1. [DOI] [PubMed] [Google Scholar]
  11. Cavaillon J. M., Leclerc C., Alouf J. E. Polyclonal antibody-forming cell activation and immunomodulation of the in vitro immune response induced by streptococcal extracellular products. Cell Immunol. 1983 Feb 15;76(1):200–206. doi: 10.1016/0008-8749(83)90362-3. [DOI] [PubMed] [Google Scholar]
  12. Cavaillon J. M., Riviere Y., Svab J., Montagnier L., Alouf J. E. Induction of interferon by streptococcus pyogenes extracellular products. Immunol Lett. 1982;5(6):323–326. doi: 10.1016/0165-2478(82)90121-3. [DOI] [PubMed] [Google Scholar]
  13. Etzioni A., Benderly A., Levy J., Grief Z., Katz R., Pollack S. Transient immunoregulatory perturbation during the acute phase of rheumatic fever. J Clin Lab Immunol. 1986 May;20(1):7–9. [PubMed] [Google Scholar]
  14. Fleischer B., Gerardy-Schahn R., Metzroth B., Carrel S., Gerlach D., Köhler W. An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction. J Immunol. 1991 Jan 1;146(1):11–17. [PubMed] [Google Scholar]
  15. Ginsburg I. Mechanisms of cell and tissue injury induced by group A streptococci: relation to poststreptococcal sequelae. J Infect Dis. 1972 Sep;126(3):294–340. doi: 10.1093/infdis/126.3.294. [DOI] [PubMed] [Google Scholar]
  16. Gray E. D., Wannamaker L. W., Ayoub E. M., el Kholy A., Abdin Z. H. Cellular immune responses to extracellular streptococcal products in rheumatic heart disease. J Clin Invest. 1981 Sep;68(3):665–671. doi: 10.1172/JCI110301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. HIRSCHHORN K., SCHREIBMAN R. R., VERBO S., GRUSKIN R. H. THE ACTION OF STREPTOLYSIN S ON PERIPHERAL LYMPHOCYTES OF NORMAL SUBJECTS AND PATIENTS WITH ACUTE RHEUMATIC FEVER. Proc Natl Acad Sci U S A. 1964 Nov;52:1151–1157. doi: 10.1073/pnas.52.5.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Imanishi K., Igarashi H., Uchiyama T. Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of V beta elements in T cell receptor of toxin-reactive T cells. J Immunol. 1990 Nov 15;145(10):3170–3176. [PubMed] [Google Scholar]
  19. Jones criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation. 1965 Oct;32(4):664–668. doi: 10.1161/01.cir.32.4.664. [DOI] [PubMed] [Google Scholar]
  20. Kawakita S., Takeuchi T., Inoue J., Onishi T., Uemura Y. Infection of group A streptococcus and antibody response to extracellular antigens. Jpn Circ J. 1981 Dec;45(12):1384–1390. doi: 10.1253/jcj.45.1384. [DOI] [PubMed] [Google Scholar]
  21. Knöll H., Gerlach D., Ozegowski J. H., Hribalová V., Köhler W. Purification and characterization of erythrogenic toxins of Streptococcus pyogenes. VI. Mitogenic activity of isoelectrically focused erythrogenic toxin preparations and culture supernatants of group A streptococci. Zentralbl Bakteriol Mikrobiol Hyg A. 1983 Nov;256(1):49–60. [PubMed] [Google Scholar]
  22. Kyhse-Andersen J. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods. 1984 Dec;10(3-4):203–209. doi: 10.1016/0165-022x(84)90040-x. [DOI] [PubMed] [Google Scholar]
  23. LANGE K., WASSERMAN E., SLOBODY L. B. The significance of serum complement levels for the diagnosis and prognosis of acute and subacute glomerulonephritis and lupus erythematosus disseminatus. Ann Intern Med. 1960 Oct;53:636–646. doi: 10.7326/0003-4819-53-4-636. [DOI] [PubMed] [Google Scholar]
  24. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  25. Majeed H. A., Karaoui R., Yousof A. M., Moussa M. A., Farwana S., Khuffash F. A. The antistreptococcal immune responses in children with acute rheumatic fever in Kuwait. Ann Trop Paediatr. 1982 Sep;2(3):133–137. doi: 10.1080/02724936.1982.11748245. [DOI] [PubMed] [Google Scholar]
  26. Martin D. R., Dick K. J. M-associated protein antibodies in patients with rheumatic fever. J Med Microbiol. 1984 Apr;17(2):189–199. doi: 10.1099/00222615-17-2-189. [DOI] [PubMed] [Google Scholar]
  27. Opelz G., Terasaki P. I., Hirata A. A. Suppression of lymphocyte transformation by aspirin. Lancet. 1973 Sep 1;2(7827):478–480. doi: 10.1016/s0140-6736(73)92073-4. [DOI] [PubMed] [Google Scholar]
  28. Parrillo J. E., Fauci A. S. Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacol Toxicol. 1979;19:179–201. doi: 10.1146/annurev.pa.19.040179.001143. [DOI] [PubMed] [Google Scholar]
  29. Quagliata F., Beckerdite Quagliata S., Alsobrook R. A., Russo C., Indiveri F., Pellegrino M. A., Ferrone S. Functional and immunological characterization of the stimulation of human lymphocytes with a mitogen from group A streptococci (SM). Cell Immunol. 1982 Mar 15;68(1):146–154. doi: 10.1016/0008-8749(82)90097-1. [DOI] [PubMed] [Google Scholar]
  30. Quagliata F., Ferrone S., Taranta A. In vivo and in vitro immunomodulatory ability of streptococcal mitogen: effects on adjuvant disease in the rat; on homograft rejection in the mouse; and on the appearance of Ia antigens on human T lymphocytes. Drugs Exp Clin Res. 1985;11(2):75–81. [PubMed] [Google Scholar]
  31. REJHOLEC V. Incidence of rheumatic fever in relation to immunologic reactivity. Ann Rheum Dis. 1957 Mar;16(1):23–30. doi: 10.1136/ard.16.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rasmussen E. O., Wuepper K. D. Purification and characterization of streptococcal proliferative factor. J Invest Dermatol. 1981 Aug;77(2):246–249. doi: 10.1111/1523-1747.ep12480148. [DOI] [PubMed] [Google Scholar]
  33. Regelmann W. E., Gray E. D., Wannamaker L. W. Characterization of the human cellular immune response to purified group A streptococcal blastogen A1. J Immunol. 1982 Apr;128(4):1631–1636. [PubMed] [Google Scholar]
  34. Schlievert P. M., Gray E. D. Group A streptococcal pyrogenic exotoxin (scarlet fever toxin) type A and blastogen A are the same protein. Infect Immun. 1989 Jun;57(6):1865–1867. doi: 10.1128/iai.57.6.1865-1867.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Senitzer D., Freimer E. H. Autoimmune mechanisms in the pathogenesis of rheumatic fever. Rev Infect Dis. 1984 Nov-Dec;6(6):832–839. doi: 10.1093/clinids/6.6.832. [DOI] [PubMed] [Google Scholar]
  36. Suzuki M., Vogt A. Mitogenic activity of extracellular cationic products produced by group A streptococci; analysis of the lymphocyte response. Clin Exp Immunol. 1986 Oct;66(1):132–138. [PMC free article] [PubMed] [Google Scholar]
  37. Watanabe N., Mikuni K., Nakamura Y. Anti-streptopolysaccharide antibody in children with rheumatic fever and scarlet fever. Jpn Circ J. 1987 Dec;51(12):1350–1352. doi: 10.1253/jcj.51.1350. [DOI] [PubMed] [Google Scholar]
  38. el-Khateeb M. S. Serological assessments of streptococcal infection by comparison of antibody titres to streptococcal extracellular antigens. J Trop Pediatr. 1988 Oct;34(5):251–253. doi: 10.1093/tropej/34.5.251. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES